HEMOFIL M - Antihemophilic Factor (Human) Method M, Monoclonal Purified
In stock
Reconfirm the price with seller
- Customer pickup,
- Courier
- In detail
Products of other enterprises
Description
The information contained in this page is intended for Indian healthcare professionals only.
HEMOFIL M is the first monoclonal antibody purified, solvent detergent-treated factor VIII therapy.1 Prepared exclusively with source plasma from Baxter's qualified donor program, HEMOFIL M has over 20 years of post-licensure clinical experience.1,2
Indications :
HEMOFIL M is indicated in hemophilia A (classical hemophilia) for the prevention and control of hemorrhagic episodes. HEMOFIL M is not indicated for von Willebrand's disease.
Features :
HEMOFIL M is the first monoclonal antibody purified, solvent detergent-treated factor VIII therapy.1 Prepared exclusively with source plasma from Baxter's qualified donor program, HEMOFIL M has over 20 years of post-licensure clinical experience.1,2
Indications :
HEMOFIL M is indicated in hemophilia A (classical hemophilia) for the prevention and control of hemorrhagic episodes. HEMOFIL M is not indicated for von Willebrand's disease.
Features :
- Use of pooled human plasma
- Patented Method M purification process
- Available in 250 IU dosage strengths
- To be stored at [2° - 8°C (36° - 46°F)] or at room temperature, not to exceed 30°C (86°F), until expiration date noted on the package. Avoid freezing to prevent damage to the diluent bottle.
Contact the seller
HEMOFIL M - Antihemophilic Factor (Human) Method M, Monoclonal Purified